Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 16 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 2973. Clear
Clear
Q1
AXADVOCACY GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View → Q4
AXADVOCACY GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View → Q3
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View → Q3
FIERCE GOVERNMENT RELATIONS for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View → Q3
FIERCE GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues
View → Q3
AXADVOCACY GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View → Q3
CENTER FOR INDIVIDUAL FREEDOM for CENTER FOR INDIVIDUAL FREEDOM
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Labor Issues/Antitrust/Workplace, Health Issues, Taxation/Internal Revenue Code, Financial Institutions/Investments/Securities
View → Q2
AXADVOCACY GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View → Q2
FIERCE GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues
View → Q2
FIERCE GOVERNMENT RELATIONS for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View → 1A
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View → Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
AXADVOCACY GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View → Q1
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q1
FIERCE GOVERNMENT RELATIONS for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View → Q1
FIERCE GOVERNMENT RELATIONS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem